+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Changes in type-specific human papillomavirus load predict progression to cervical cancer

Changes in type-specific human papillomavirus load predict progression to cervical cancer

Journal of Cellular and Molecular Medicine 16(12): 3096-3104

Persistent high-risk human papillomavirus (HPV) infection is strongly associated with the development of high-grade cervical intraepithelial neoplasia or cancer (CIN3+). However, HPV infection is common and usually transient. Viral load measured at a single time-point is a poor predictor of the natural history of HPV infection. The profile of viral load evolution over time could distinguish HPV infections with carcinogenic potential from infections that regress. A case-cohort natural history study was set-up using a Belgian laboratory database processing more than 100,000 liquid cytology specimens annually. All cytology leftovers were submitted to real-time PCR testing identifying E6/E7 genes of 17 HPV types, with viral load expressed as HPV copies/cell. Samples from untreated women who developed CIN3+ (n = 138) and women with transient HPV infection (n = 601) who contributed at least three viral load measurements were studied. Only single-type HPV infections were selected. The changes in viral load over time were assessed by the linear regression slope for the productive and/or clearing phase of infection in women developing CIN3+ and women with transient infection respectively. Transient HPV infections generated similar increasing (0.21 copies/cell/day) and decreasing (-0.28 copies/cell/day) viral load slopes. In HPV infections leading to CIN3+, the viral load increased almost linearly with a slope of 0.0028 copies/cell/day. Difference in slopes between transient infections and infections leading to CIN3+ was highly significant (P < .0001). Serial type-specific viral load measurements predict the natural history of HPV infections and could be used to triage women in HPV-based cervical cancer screening.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 036580075

Download citation: RISBibTeXText

PMID: 22978795

DOI: 10.1111/j.1582-4934.2012.01631.x

Related references

The use of viral load as a surrogate marker in predicting disease progression for patients with early invasive cervical cancer with integrated human papillomavirus type 16. American Journal of Obstetrics and Gynecology 201(1): 79.E1-7, 2009

Serial measurement of type-specific human papillomavirus load enables classification of cervical intraepithelial neoplasia lesions according to occurring human papillomavirus-induced pathway. European Journal of Cancer Prevention 26(2): 156-164, 2016

Effects of human papillomavirus type-specific antisense oligonucleotides on cervical cancer cells containing papillomavirus type 16. Medical Oncology 11(3-4): 149-151, 1994

Analysis of human papillomavirus type 18 load and integration status from low-grade cervical lesion to invasive cervical cancer. Journal of Clinical Microbiology 47(2): 287-293, 2008

Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer. European Journal of Obstetrics, Gynecology, and Reproductive Biology 130(2): 223-231, 2006

Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer. Journal of Virology 73(7): 5402-5410, 1999

Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ. International Journal of Cancer 112(5): 854-859, 2004

Human papillomavirus type specific DNA and RNA persistence--implications for cervical disease progression and monitoring. Journal of Medical Virology 73(1): 65-70, 2004

Human papillomavirus type 16 viral load in relation to HIV infection, cervical neoplasia and cancer in Senegal. Cancer Epidemiology 38(4): 369-375, 2015

Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer. Cancer Epidemiology, Biomarkers & Prevention 14(5): 1311-1314, 2005

Human papillomavirus type specific risk of progression and remission during long-term follow-up of equivocal and low-grade HPV-positive cervical smears. International Journal of Cancer 143(4): 851-860, 2018

Hypoxia-inducible factor-1 facilitates cervical cancer progression in human papillomavirus type 16 transgenic mice. American Journal of Pathology 171(2): 667-681, 2007

Physical state & copy number of high risk human papillomavirus type 16 DNA in progression of cervical cancer. Indian Journal of Medical Research 139(4): 531-543, 2015

The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States. International Journal of Cancer 135(3): 624-634, 2014

Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiology, Biomarkers and Prevention 18(1): 113-120, 2009